The Leber Hereditary Optic Neuropathy Treatment market was valued at USD 350.19 Million in 2022 and is expected to reach USD 627.75 Million by 2030, growing at a CAGR of 6.7% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.